Literature DB >> 7357031

Purification, radioimmunoassay, and distribution of human brain 14-3-2 protein (nervous-system specific enolase) in human tissues.

D A Hullin, K Brown, P A Kynoch, C Smith, R J Thompson.   

Abstract

Human 14-3-2 protein, a nervous-system specific enolase (EC 4.2.1.11) isoenzyme, has been purified from human brain and a sensitive radioimmunoassay has been developed for its detection. A systematic survey of human organs has shown that immunoreactive nervous-system specific enolase is present in all human organs but at levels less than 3% of those found in human brain, with especially low levels in liver, kidney and skeletal muscle, and with the highest levels in adrenal and large intestine. In all organs immunoreactive nervous-system specific enolase occurs in two forms representing the heterodimer and homodimer forms of the enzyme, and in all tissues except brain the heterodimer predominates. The presence of nervous-system specific enolase in other organs is unlikely to be explicable by innervation alone since significant quantities are found in red blood cell haemolysates. Tissues which contain amine precursor uptake and decarboxylation cells, for which the protein has been claimed to be a specific molecular marker, do not contain significantly higher levels of immunoreactive nervous-system specific enolase than other tissues. Both the heterodimer and homodimer forms of the enolase appear to be expressed at low levels in all tissues.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7357031     DOI: 10.1016/0304-4165(80)90355-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Preparation and purification of gamma gamma enolase (neuron-specific enolase) using high performance anion exchange chromatography.

Authors:  J L Viallard; M R Ven Murthy; B Dastugue
Journal:  Neurochem Res       Date:  1988-01       Impact factor: 3.996

2.  Neuron-specific enolase, but not S100B or myelin basic protein, increases in peripheral blood corresponding to lesion volume after cortical impact in piglets.

Authors:  Beth A Costine; Patricia B Quebeda-Clerkin; Carter P Dodge; Brent T Harris; Simon C Hillier; Ann-Christine Duhaime
Journal:  J Neurotrauma       Date:  2012-09-27       Impact factor: 5.269

3.  A compilation of amino acid analyses of proteins. XVIII. Residues per thousand residues--5.

Authors:  D M Kirschenbaum
Journal:  Appl Biochem Biotechnol       Date:  1983-08       Impact factor: 2.926

4.  Production and characterization of monoclonal antibodies against the "brain-specific" proteins 14-3-2 and S-100.

Authors:  E A Haan; B D Boss; W M Cowan
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

5.  Phosphoglycerate mutase, 2,3-bisphosphoglycerate phosphatase and enolase activity and isoenzymes in lung, colon and liver carcinomas.

Authors:  N Durany; J Joseph; E Campo; R Molina; J Carreras
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

6.  Gamma-enolase activity in choroidal melanoma.

Authors:  C E Margo; M Lavellée
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

7.  Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.

Authors:  B S Shine; J Hungerford; B Vaghela; G A Sheraidah
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

8.  Neural markers in carcinoma of the lung.

Authors:  A P Dhillon; J Rode; D P Dhillon; E Moss; R J Thompson; S G Spiro; B Corrin
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

9.  Distinction of two different classes of small-cell lung cancer cell lines by enzymatically inactive neuron-specific enolase.

Authors:  T A Splinter; C F Verkoelen; M Vlastuin; T C Kok; G Rijksen; K G Haglid; F Boomsma; A van de Gaast
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.